A starting price needs context
An NAD+ cost-planning index that distinguishes a published starting price from a complete quote, with clear questions about plan length, included services and unconfirmed Cyber Monday terms.
Explore the detailsA closer look
CoreAge Rx’s NAD+ Injectable listing advertises a starting price of $93 per month. That is the verified commercial starting point, not a complete personal quote or a holiday reduction. This index helps you identify the information still needed to understand a proposed payment: the preparation, covered period, included services and continuing conditions.
We promote CoreAge Rx. No NAD+ holiday discount or Cyber Monday offer was verified as of November 7, 2026. Verified Black Friday campaigns for other products end November 27, before Cyber Monday on November 30; those terms do not establish an NAD+ promotion. Prescribing and final charges require direct confirmation.
Sponsored · CoreAge Rx
A Cyber Monday promotion has not been verified. The links below show current provider pages; Black Friday terms do not establish a Cyber Monday offer.
Regular product listing
Provider-advertised starting price
No Black Friday or Cyber Monday discount has been verified. Confirm the total plan cost and current terms with CoreAge Rx.
Compounded medication is not FDA-approved. A clinician must assess your needs; a prescription is not guaranteed.
Provider sourcePromotional placement. This publication is part of a commonly owned promotional network supporting CoreAge Rx. Placement is not an independent ranking or a claim that treatment is appropriate for you. How this site works.
The reading room
Identify the fields an NAD+ quote would need to explain before a published monthly starting figure could support a realistic assessment of the commitment.
Build a useful cost note by distinguishing observed prices, provider answers and unresolved assumptions without inventing a holiday reduction or an all-inclusive treatment total.
Take this with you
What exact NAD+ preparation and plan does the advertised starting price describe?
What would the full amount payable now include or exclude?
What minimum period, renewal schedule and cancellation terms would apply?
Which clinical assessment must occur before any treatment could be prescribed?
Before you decide
No. CoreAge Rx’s general NAD+ Injectable page advertises a starting price of $93 per month. No NAD+ holiday discount was verified. The source review did not establish a minimum commitment, complete checkout price or individualized quote.
A starting price alone does not establish the exact preparation, total commitment, included services or renewal arrangement for a particular order. Ask the provider to explain those fields together. A monthly label cannot supply terms that were not verified.
No. It means a Cyber Monday offer was not confirmed as of November 7, 2026. The checked holiday routes did not establish one. That finding should not be expanded into a claim about every possible current or future provider offer.
No. Price describes a commercial term, while suitability requires clinical assessment. CoreAge Rx labels the offered preparation compounded; it is not FDA-approved. Ask the clinician about your concern, the proposed formulation and evidence relevant to that decision.